These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4559100)

  • 81. Fluctuating levels of LH-RH in pituitary portal blood during the cycle after castration.
    Res Reprod; 1977 May; 9(3):2. PubMed ID: 12326804
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Pulsatile treatment with gonadotropin-releasing hormone (Gn-RH)].
    Leyendecker G; Wildt L
    Geburtshilfe Frauenheilkd; 1982 Sep; 42(9):689-99. PubMed ID: 6754523
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Diagnosis and ovulation induction with LH-RH].
    Mizuguchi H; Mori H; Tamura T; Sakamoto M
    Horumon To Rinsho; 1973 Apr; 21(4):365-72. PubMed ID: 4581591
    [No Abstract]   [Full Text] [Related]  

  • 84. [Induction of ovulation: Comparative study on the response of the ovary to the treatment with human gonadotropins, synthetic hypothalamic gonadotropin-releasing hormone (LH-RH) and nonhormonal agents (clomiphene, cyclophenyl, etc). Therapeutic studies on the treatment of anovulatory sterility].
    Zañartu J; Dabancens A; Rodríguez-Bravo R; Schally AV
    Rev Chil Obstet Ginecol; 1973; 38(5):240-51. PubMed ID: 4619840
    [No Abstract]   [Full Text] [Related]  

  • 85. Effect of synthetic hypothalamic gonadotropin-releasing hormone (FSH-LH-RH) in anovulatory sterility.
    Zanartu J; Dabancens A; Kastin AJ; Schally AV
    Fertil Steril; 1974 Feb; 25(2):160-9. PubMed ID: 4590125
    [No Abstract]   [Full Text] [Related]  

  • 86. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pulsatile subcutaneous low-dose gonadotropin-releasing hormone treatment of anovulatory infertility.
    Skarin G; Nillius SJ; Wide L
    Fertil Steril; 1983 Oct; 40(4):454-60. PubMed ID: 6413261
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Ovulation induction with gonadotropin-releasing hormone].
    Moen MH; Abyholm T
    Tidsskr Nor Laegeforen; 1987 Aug; 107(23):1883-4. PubMed ID: 3310328
    [No Abstract]   [Full Text] [Related]  

  • 90. Induction of ovulation with gonadotrophin-releasing hormone--life-table analysis of 50 courses of treatment.
    Kovacs GT; Phillips S; Healy DL; Burger HG
    Med J Aust; 1989 Jul; 151(1):21, 24-6. PubMed ID: 2671613
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Synthetic luteinizing releasing hormone and its clinical application].
    Nakano R; Kotsuji F
    Nihon Naibunpi Gakkai Zasshi; 1972 May; 48(2):115-21. PubMed ID: 4561126
    [No Abstract]   [Full Text] [Related]  

  • 92. Ovulation induced by synthetic luteinizing hormone releasing factor in androgen-sterilized female rats.
    Borvendég J; Hermann H; Bajusz S
    J Endocrinol; 1972 Oct; 55(1):207-8. PubMed ID: 4574279
    [No Abstract]   [Full Text] [Related]  

  • 93. A normal cumulative conception rate after human pituitary gonadotropin.
    Healy DL; Kovacs GT; Pepperell RJ; Burger HG
    Fertil Steril; 1980 Oct; 34(4):341-5. PubMed ID: 6252067
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The response of patients with organic hypothalamic-pituitary disease to pulsatile gonadotropin-releasing hormone therapy.
    Morris DV; Abdulwahid NA; Armar A; Jacobs HS
    Fertil Steril; 1987 Jan; 47(1):54-9. PubMed ID: 3539644
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ovulation and pregnancy after pulsatile administration of gonadotropin releasing hormone.
    Berg D; Mickan H; Michael S; Döring K; Gloning K; Jänicke F; Rjosk HK
    Arch Gynecol; 1983; 233(3):205-10. PubMed ID: 6354104
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ovulation induction and pregnancy in hypothalamic amenorrhea using self-administered intravenous gonadotropin-releasing hormone.
    Goerzen J; Corenblum B; Wiseman DA; Taylor PJ
    Fertil Steril; 1984 Feb; 41(2):319-21. PubMed ID: 6365602
    [No Abstract]   [Full Text] [Related]  

  • 97. Therapeutic aspects of LH-RH in ovarian insufficiency.
    Lehmann F; Bettendorf G; Breckwoldt M; Czygan PJ
    Acta Endocrinol Suppl (Copenh); 1973; 173():90. PubMed ID: 4579939
    [No Abstract]   [Full Text] [Related]  

  • 98. Influence of the tripeptide, PRO-ARG-GLY-(NH2), on ovulation induced with LH or synthetic LH-FSH releasing hormone in chlorpromazine-treated pro-oestrous rats.
    de la Lastra M; Forcelledo ML; Stewart JM
    J Reprod Fertil; 1973 Sep; 34(3):531-4. PubMed ID: 4582266
    [No Abstract]   [Full Text] [Related]  

  • 99. Ovulation and serum luteinizing hormone in the cycling rat following administration of gonadotropin releasing hormone.
    Rippel RH; Johnson ES; White WF
    Proc Soc Exp Biol Med; 1973 May; 143(1):55-8. PubMed ID: 4574124
    [No Abstract]   [Full Text] [Related]  

  • 100. LH-secretion after synthetic LH-RH in the male under normal and pathological conditions.
    Schulz F; Guthoff R; Müller A; Retiene K
    Acta Endocrinol Suppl (Copenh); 1973; 173():93. PubMed ID: 4579942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.